Budesonide: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Budesonide. Educational only — not medical advice.
Reported adverse reactions
| Reaction | Highest frequency reported* |
|---|---|
| Respiratory infection | 38% |
| Rhinitis | 12% |
| Otitis media | 12% |
| Coughing | 9% |
| Viral infection | 5% |
| Gastroenteritis | 5% |
| Ear infection | 5% |
| Moniliasis | 4% |
| Vomiting | 4% |
| Diarrhea | 4% |
| Epistaxis | 4% |
| Conjunctivitis | 4% |
| Rash | 4% |
| Abdominal pain | 3% |
*Highest percentage across placebo-controlled trial tables summarized in current labeling.
Labeled uses
1.1 Maintenance Treatment of Asthma Budesonide inhalation suspension is indicated for the maintenance treatment of asthma and as prophylactic therapy in children 12 months to 8 years of age. Limitations of Use: Budesonide inhalation suspension is NOT indicated for the relief of acute bronchospasm.
Source: FDA labeling via NIH DailyMed (set d2178406…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.